Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion.

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

The American Lung Association in South Carolina is set to host the "Lowcountry Dancing with the Stars" Oxygen Ball on Friday, ...

Final phase 2a results showed that CAN-2409 led to a median overall survival of 24.5 months in immune checkpoint ...

New research led by American Cancer Society (ACS) researchers estimates more than 3.8 million lung cancer deaths were averted ...

Compared with same-aged adults who are cancer-free, older adults with cancer have a lower risk of developing Alzheimer disease and related dementias.

The New York State Senate has unanimously passed Senate Bill S. 2000, a significant step toward improving the early detection ...

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...